S100 Proteins and Annexins
S100 Proteins and Annexins is a research topic within Molecular Biology. Science Explorer counts 27k research works in it since 1950. 18.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the structure, function, and pathology of S100 proteins, a multigenic family of calcium-modulated proteins with roles in inflammation, neurodegeneration, cancer biomarkers, traumatic brain injury, innate immunity, glial fibrillary acidic protein, metastasis, and phagocytes.
- S100 Proteins
- Inflammation
- Calcium Modulated Proteins
- Neurodegeneration
- Cancer Biomarkers
- Traumatic Brain Injury
- Innate Immunity
- Glial Fibrillary Acidic Protein
- Metastasis
- Phagocytes
- Research works
- 27k fractional, since 1950
- In the world top 10%
- 4.8k per year above
- Top-10% rate
- 18.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +7% the tick is no change
Which countries lead S100 Proteins and Annexins research?
By volume, China and the United States publish the most (1.2k and 776 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.2k works
- 2 United States 776 works
- 3 Germany 174 works
- 4 Japan 133 works
- 5 United Kingdom 132 works
- 6 Russia 129 works
- 7 India 127 works
- 8 Italy 106 works
- 9 Canada 80 works
- 10 Spain 79 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead S100 Proteins and Annexins research?
By volume in 2022–2025, Capital Medical University publishes the most S100 Proteins and Annexins research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Nanjing Medical University.
By volume, 2022–2025
- 1 Capital Medical UniversityChina 20 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 16 works
- 3 Nanjing Medical UniversityChina 14 works
- 4 University of GothenburgSweden 12 works
- 5 Central South UniversityChina 12 works
- 6 Shanghai Jiao Tong UniversityChina 12 works
- 7 Sun Yat-sen UniversityChina 11 works
- 8 Sichuan UniversityChina 11 works
- 9 China Medical UniversityChina 11 works
- 10 Southern Medical UniversityChina 11 works
Who are the leading researchers in S100 Proteins and Annexins?
The most-cited researchers publishing on S100 Proteins and Annexins include Dirk Schadendorf, Hugo A. Katus and Yi Zhang.
- 1 Dirk Schadendorf Germany 4.4k citations
- 2 Hugo A. Katus Germany 3.8k citations
- 3 Yi Zhang China 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is S100 Proteins and Annexins research done?
The largest centres of S100 Proteins and Annexins research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Moscow (Russia). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 23.4 works5.0×
Location quotient: how much more of its research is in S100 Proteins and Annexins than the world average.
Where is the best place to study S100 Proteins and Annexins?
Among universities, judged by research, Capital Medical University, University of Gothenburg and China Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Capital Medical UniversityChina | 72.3 | 25.4% | 9.2× | 20 | +37.7% |
| 2 | University of GothenburgSweden | 65.5 | 29.3% | 8.2× | 12 | +1.5% |
| 3 | China Medical UniversityChina | 59.1 | 30.4% | 9.1× | 11 | -17.1% |
| 4 | Sichuan UniversityChina | 50.2 | 29.0% | 1.7× | 11 | +110.9% |
| 5 | Nanjing Medical UniversityChina | 48.4 | 18.5% | 7.3× | 14 | +27.9% |
| 6 | Huazhong University of Science and TechnologyChina | 46.6 | 32.3% | 1.8× | 11 | +35.5% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 44.2 | 22.5% | 4.5× | 16 | -25.9% |
| 8 | Harvard UniversityUnited States | 44.2 | 31.1% | 2.1× | 10 | -8.0% |
| 9 | Karolinska InstitutetSweden | 43.6 | 21.0% | 5.1× | 8 | +29.6% |
| 10 | Wuhan UniversityChina | 42.3 | 27.9% | 2.2× | 10 | +43.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is S100 Proteins and Annexins research growing?
Output in 2018–2022 was 7% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are S100 Proteins and Annexins.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.